Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Wow
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(577)
•••
Comment by Quattro74on Aug 19, 2020 5:57pm
151 Views
Post# 31430912

RE:RE:RE:RE:RE:RE:RE:RE:Wow

RE:RE:RE:RE:RE:RE:RE:RE:Wow
Hempdoc wrote:

 

skys1 wrote: Like I said a week or so ago. I believe 1433 will be the Company's life line and will become so valuable that in time a member of the big pharma community will be forced to try to take us out to have unlimited access and control of it. That move would certainly have to be in the $billions.

 

 

Happy to see Billions....RPCCC, UM & other publicly-financed institutions are pure academic/research centers, which suits us well.  They are not generally concerned with "commercial" success/outcomes, but are rather laser-focused on the scientific & clinical results.  I can't be happier that they've joined the TLT party as this type of research/backing is as unbiased as it gets.  As a result, I agree that Big Pharma will soon be salivating & all over this as the data/evidence builds. Good luck...



Been flyin' under the radar soo long, now TLT will be flying high! ;-)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities